organization

ADLEGO BIOMEDICAL AB

  • project . 2020 - 2022
    Funder: EC Project Code: 101003555
    Overall Budget: 2,807,030 EURFunder Contribution: 2,807,030 EUR
    Open Access mandate for Publications
    Partners: Stockholm University, University of Duisburg-Essen, ADLEGO BIOMEDICAL AB, AU, CEA, University of Ulm

    Project coordinator: Professor Anna-Lena Spetz, MD, PhD, Stockholm University, Sweden Objectives of proposal: Our consortium “Fight-nCoV” will accelerate preclinical development of new broad-spectrum antivirals for inhalation, building on breath-taking ongoing research....

  • project . 2020 - 2022
    Funder: EC Project Code: 101003666
    Overall Budget: 3,000,000 EURFunder Contribution: 3,000,000 EUR
    Open Access mandate for Publications
    Partners: Karolinska Institutet Innovations (Sweden), ADLEGO BIOMEDICAL AB, IGEA SPA, RS, FOHM, Justus-Liebig University Giessen, COBRA BIOPHARMA

    The OPENCORONA consortia will test a therapy that protects against 2019-nCoV infection and/or disease in a phase I clinical trial in 24 months. The spread of the 2019-nCoV (or SARS-CoV-2) between the Jan 21 and Feb 11 has expanded alarmingly. There are >43000 confirmed ...

  • project . 2014 - 2017
    Funder: EC Project Code: 602080
    Open Access mandate for Publications Special Clause 39
    Partners: UMESP, University of Freiburg, UNIRIO, UFV, Griffith University, MLU, ADLEGO BIOMEDICAL AB, UEA, CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE, INSERM...
Any information missing or wrong?Report an Issue